Kidney cancer research program services in support of congressionally directed medical research programs
Ended Awarded Last action
- Contract number
- W81XWH20F0328
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $630,744
Award facts
- Opportunity
-
- W81XWH17R0036 Solicitation number
- Meeting, Scientific and Administrative Support Services (MSASS), Request for Proposal (RFP) Award Notice · Posted Apr 12, 2017
- Meeting, Scientific and Administrative Support Services Award Notice · Posted Mar 22, 2017
- Contract value 91% obligated
-
- $630,743.75 Current, with exercised options
- $696,220.87 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Two Step
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $1,583 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | -$37,133 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $252,056 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $240,223 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $174,015 |
About this award
The Defense Health Agency issued a delivery order to Leidos, Inc. on July 30, 2020, with a ceiling value of $696,220.87 under a cost-plus-fixed-fee arrangement. The order, which completed on July 29, 2023, supported kidney cancer research program services including vision setting, pre-application screening, programmatic review, and general program support within the Congressionally Directed Medical Research Programs.
Place of performance was Frederick, Maryland. No set-aside was used for this order.
Quick answers
Who was awarded contract W81XWH20F0328?
W81XWH20F0328 was awarded to Leidos, Inc. by Medical Command (Department of the Army) on July 30, 2020.
How much is contract W81XWH20F0328 worth?
The government has obligated $630,744 on W81XWH20F0328. Its potential value, with all options, is $696,221.
Which agency awarded contract W81XWH20F0328?
Medical Command (Department of the Army) awarded W81XWH20F0328, with funding from Defense Health Agency (Department of Defense).
Is contract W81XWH20F0328 an order under another contract?
Yes. W81XWH20F0328 is a delivery order under W81XWH17D0025, an indefinite delivery contract.
Was contract W81XWH20F0328 competed?
The extent of competition for W81XWH20F0328 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award